Chemed (NYSE:CHE) Announces Quarterly Earnings Results, Beats Estimates By $0.46 EPS

Chemed (NYSE:CHE) issued its quarterly earnings results on Tuesday. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46, FiscalAI reports. The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the firm earned $4.27 EPS. Chemed updated its FY 2026 guidance to 25.000-25.750 EPS.

Chemed Price Performance

NYSE CHE traded up $6.75 on Tuesday, reaching $516.09. The company’s stock had a trading volume of 198,346 shares, compared to its average volume of 222,962. Chemed has a 52 week low of $365.20 and a 52 week high of $520.01. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The firm has a market cap of $6.85 billion, a PE ratio of 28.12, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52. The business has a 50-day moving average price of $459.92 and a 200 day moving average price of $434.09.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is 13.08%.

Analyst Ratings Changes

A number of brokerages have recently commented on CHE. Bank of America upped their price objective on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Royal Bank Of Canada boosted their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $480.25.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 3.33% of the company’s stock.

Hedge Funds Weigh In On Chemed

Several institutional investors have recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC boosted its position in Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after buying an additional 22 shares in the last quarter. Cim LLC increased its holdings in shares of Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after buying an additional 24 shares in the last quarter. Merit Financial Group LLC raised its stake in shares of Chemed by 4.0% in the third quarter. Merit Financial Group LLC now owns 940 shares of the company’s stock valued at $421,000 after acquiring an additional 36 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Chemed by 1.2% in the fourth quarter. Deutsche Bank AG now owns 2,929 shares of the company’s stock valued at $1,253,000 after acquiring an additional 36 shares during the last quarter. Finally, Public Employees Retirement System of Ohio raised its stake in shares of Chemed by 0.8% in the third quarter. Public Employees Retirement System of Ohio now owns 5,007 shares of the company’s stock valued at $2,242,000 after acquiring an additional 40 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.